Traveka Wealth, LLC Novartis Ag Transaction History
Traveka Wealth, LLC
- $197 Billion
- Q3 2024
A detailed history of Traveka Wealth, LLC transactions in Novartis Ag stock. As of the latest transaction made, Traveka Wealth, LLC holds 3,525 shares of NVS stock, worth $377,457. This represents 0.21% of its overall portfolio holdings.
Number of Shares
3,525
Previous 3,397
3.77%
Holding current value
$377,457
Previous $362 Million
12.11%
% of portfolio
0.21%
Previous 0.18%
Shares
4 transactions
Others Institutions Holding NVS
# of Institutions
1,432Shares Held
138MCall Options Held
1.48MPut Options Held
1.55M-
Dodge & Cox San Francisco, CA12.2MShares$1.31 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.3 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$867 Million0.23% of portfolio
-
Morgan Stanley New York, NY7.42MShares$794 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.95MShares$637 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...